Point72 Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Point72 Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.19M	Sell	12,600 -3,400	-21%	-$1.85M	0.01%	1552
2025 Q4	$9.27M	Buy	16,000 +10,300	+181%	+$5.82M	0.01%	1404
2025 Q3	$2.76M	Sell	5,700 -1,200	-17%	-$559K	﹤0.01%	1315
2025 Q2	$2.8M	Sell	6,900 -4,100	-37%	-$1.71M	0.01%	1170
2025 Q1	$5.47M	Buy	11,000 +100	+0.9%	+$54.2K	0.01%	893
2024 Q4	$5.67M	Buy	10,900 +2,200	+25%	+$1.21M	0.01%	908
2024 Q3	$5.38M	Buy	+8,700	New	+$5.15M	0.01%	865
2024 Q1	–	Sell	-25,000	Closed	-$13.3M	–	2621
2023 Q4	$13.3M	Buy	+25,000	New	+$12.1M	0.03%	589

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management's TMO Position: Q1 2026 in Review

Point72 Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, selling an estimated $45.2M and leaving 353,541 shares worth $174M. The position accounts for 0.22% of the portfolio, ranked #68.

Point72 Asset Management first reported a position in TMO in Q2 2014 and has held it in 32 quarters since. The position peaked at $253M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Point72 Asset Management held 353,541 shares of Thermo Fisher Scientific worth $174M as of Q1 2026.
Point72 Asset Management sold 83,317 Thermo Fisher Scientific shares in Q1 2026, an estimated $45.2M.
Thermo Fisher Scientific made up 0.22% of Point72 Asset Management's portfolio in Q1 2026, its #68 holding.
Point72 Asset Management first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 32 quarters since.
Point72 Asset Management's Thermo Fisher Scientific position peaked at $253M in Q4 2025.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.